Strategies for engineered negligible senescence
Related Experiment Video
Updated: May 18, 2026

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
Ben Zealley1, Aubrey D N J de Grey
1SENS Foundation, Mountain View, CA 94041, USA.
Abstract:
In this viewpoint, we describe the strategies for engineered negligible senescence (SENS) concept--a simple and appealing model for the design of therapeutic interventions able to meaningfully and persistently reverse the deleterious effects of aging. We go on to outline how current or foreseeable biotechnologies could feasibly be employed to repair every currently identified category of pathogenic damage that accumulates over a human lifespan. Then, briefly, we explain why this goal is not only ethically sound, but can in fact be considered to verge on an ethical obligation. Finally, we review recent progress in some key areas of the SENS platform, including proof-of-concept research sponsored by the SENS Foundation, a charity based in California.
Related Concept Videos
Replicative Cell Senescence
Replicative Cell Senescence
In-vitro Mutagenesis
Bioreactor Controls-III

